Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meagan B Myers

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Pharmacogenomics and Personalized Medicine|February 10, 2016
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectivesMeagan B Myers
Personalized Medicine|November 22, 2016
<i>KRAS</i> mutant tumor subpopulations can subvert durable responses to personalized cancer treatmentsBarbara L Parsons, Meagan B Myers
Discovery Medicine|May 3, 2013
Personalized cancer treatment and the myth of KRAS wild-type colon tumorsBarbara L Parsons, Meagan B Myers
Methods in Molecular Biology (Clifton, N.J.)|April 11, 2023
A Brief Practical Guide to PCRPage B McKinzie, Meagan B Myers
Environmental and Molecular Mutagenesis|July 30, 2017
Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomasBarbara L Parsons, Karen L McKim, Meagan B Myers
Biotechniques|October 27, 2009
Using phiX174 DNA as an exogenous reference for measuring mitochondrial DNA copy numberMeagan B Myers, Roberta A Mittelstaedt, Robert H Heflich
Molecular Carcinogenesis|August 30, 2012
A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroidMeagan B Myers, Karen L McKim, Barbara L Parsons
Personalized Medicine|March 1, 2015
Low-frequency <i>KRAS</i> mutations are prevalent in lung adenocarcinomasMeagan B Myers, Karen L McKim, Fanxue Meng, et al.
Expert Review of Molecular Diagnostics|August 1, 2012
Hotspot oncomutations: implications for personalized cancer treatmentMeagan B Myers, Yiying Wang, Karen L McKim, et al.
Mutation Research|April 26, 2003
Accumulation of point mutations in mitochondrial DNA of aging miceMagomed Khaidakov, Robert H Heflich, Mugimane G Manjanatha, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pharmacogenomics and Personalized Medicine|February 10, 2016
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectivesMeagan B Myers
Personalized Medicine|November 22, 2016
<i>KRAS</i> mutant tumor subpopulations can subvert durable responses to personalized cancer treatmentsBarbara L Parsons, Meagan B Myers
Discovery Medicine|May 3, 2013
Personalized cancer treatment and the myth of KRAS wild-type colon tumorsBarbara L Parsons, Meagan B Myers
Methods in Molecular Biology (Clifton, N.J.)|April 11, 2023
A Brief Practical Guide to PCRPage B McKinzie, Meagan B Myers
Environmental and Molecular Mutagenesis|July 30, 2017
Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomasBarbara L Parsons, Karen L McKim, Meagan B Myers
Biotechniques|October 27, 2009
Using phiX174 DNA as an exogenous reference for measuring mitochondrial DNA copy numberMeagan B Myers, Roberta A Mittelstaedt, Robert H Heflich
Molecular Carcinogenesis|August 30, 2012
A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroidMeagan B Myers, Karen L McKim, Barbara L Parsons
Personalized Medicine|March 1, 2015
Low-frequency <i>KRAS</i> mutations are prevalent in lung adenocarcinomasMeagan B Myers, Karen L McKim, Fanxue Meng, et al.
Expert Review of Molecular Diagnostics|August 1, 2012
Hotspot oncomutations: implications for personalized cancer treatmentMeagan B Myers, Yiying Wang, Karen L McKim, et al.
Mutation Research|April 26, 2003
Accumulation of point mutations in mitochondrial DNA of aging miceMagomed Khaidakov, Robert H Heflich, Mugimane G Manjanatha, et al.
Pageof 4